These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23972663)

  • 21. Role of DNA minor groove alkylation and DNA cross-linking in the cytotoxicity of polybenzamide mustards.
    Turner PR; Denny WA; Ferguson LR
    Anticancer Drug Des; 2000 Aug; 15(4):245-53. PubMed ID: 11200500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A powerful selection assay for mixture libraries of DNA alkylating agents.
    Ham YW; Boger DL
    J Am Chem Soc; 2004 Aug; 126(30):9194-5. PubMed ID: 15281804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bendamustine hydrochloride - a renaissance of alkylating strategies in anticancer medicine.
    Eichbaum M; Bischofs E; Nehls K; Schneeweiss A; Sohn C
    Drugs Today (Barc); 2009 Jun; 45(6):431-44. PubMed ID: 19649333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.
    Kaina B; Christmann M; Naumann S; Roos WP
    DNA Repair (Amst); 2007 Aug; 6(8):1079-99. PubMed ID: 17485253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence-specific DNA interactions by novel alkylating anthracycline derivatives.
    Marchini S; Gonzalez Paz O; Ripamonti M; Geroni C; Bargiotti A; Caruso M; Todeschi S; D'Incalci M; Broggini M
    Anticancer Drug Des; 1995 Dec; 10(8):641-53. PubMed ID: 8595123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sliding of alkylating anticancer drugs along the minor groove of DNA: new insights on sequence selectivity.
    Vargiu AV; Ruggerone P; Magistrato A; Carloni P
    Biophys J; 2008 Jan; 94(2):550-61. PubMed ID: 18160662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of RNA polymerase II stalling by DNA alkylation.
    Malvezzi S; Farnung L; Aloisi CMN; Angelov T; Cramer P; Sturla SJ
    Proc Natl Acad Sci U S A; 2017 Nov; 114(46):12172-12177. PubMed ID: 29087308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumour imidazotetrazines. Part 37. Conjugation of the DNA major-groove alkylating imidazotetrazine mitozolomide to peptide motifs recognizing the minor groove.
    Arrowsmith J; Missailidis S; Stevens MF
    Anticancer Drug Des; 1999 Jun; 14(3):205-17. PubMed ID: 10500496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repair of alkylated DNA: recent advances.
    Sedgwick B; Bates PA; Paik J; Jacobs SC; Lindahl T
    DNA Repair (Amst); 2007 Apr; 6(4):429-42. PubMed ID: 17112791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of transcription factor--DNA interactions by anticancer drugs.
    Broggini M; D'Incalci M
    Anticancer Drug Des; 1994 Aug; 9(4):373-87. PubMed ID: 7916903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on MGMT assay and tumor individual predictable chemotherapy].
    Zhang YP
    Ai Zheng; 2004 Jun; 23(6):724-34. PubMed ID: 15191682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alkylating agents, mechanisms of resistance: a review.
    Fox BW
    Prog Clin Biol Res; 1983; 132C():247-55. PubMed ID: 6314356
    [No Abstract]   [Full Text] [Related]  

  • 33. DNA minor groove binders: back in the groove.
    Cai X; Gray PJ; Von Hoff DD
    Cancer Treat Rev; 2009 Aug; 35(5):437-50. PubMed ID: 19328629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis of DNA alkylation by conjugates between pyrrole-imidazole hairpin polyamides and chlorambucil or seco-CBI.
    Minoshima M; Bando T; Shinohara K; Kashiwazaki G; Nishijima S; Sugiyama H
    Bioorg Med Chem; 2010 Feb; 18(3):1236-43. PubMed ID: 20074970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and DNA cleavage activity of Bis-3-chloropiperidines as alkylating agents.
    Zuravka I; Roesmann R; Sosic A; Wende W; Pingoud A; Gatto B; Göttlich R
    ChemMedChem; 2014 Sep; 9(9):2178-85. PubMed ID: 24616300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines.
    Cloutier JF; Castonguay A; O'Connor TR; Drouin R
    J Mol Biol; 2001 Feb; 306(2):169-88. PubMed ID: 11237592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of novel caged DNA alkylating agents bearing 3,4-epoxypiperidine structure.
    Kawada Y; Kodama T; Miyashita K; Imanishi T; Obika S
    Org Biomol Chem; 2012 Jul; 10(26):5102-8. PubMed ID: 22614066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alkylation of duplex DNA in nucleosome core particles by duocarmycin SA and yatakemycin.
    Trzupek JD; Gottesfeld JM; Boger DL
    Nat Chem Biol; 2006 Feb; 2(2):79-82. PubMed ID: 16415862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profiling the Nucleobase and Structure Selectivity of Anticancer Drugs and other DNA Alkylating Agents by RNA Sequencing.
    Sauter B; Gillingham D
    Chembiochem; 2018 Aug; 19(15):1638-1642. PubMed ID: 29732707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA repair in resistance to bifunctional alkylating and platinating agents.
    Murray D
    Cancer Treat Res; 2002; 112():129-60. PubMed ID: 12481715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.